MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1
- PMID: 22198213
- DOI: 10.1093/carcin/bgr304
MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1
Abstract
MicroRNA-34a (miR-34a), a transcriptional target of p53, is a well-known tumor suppressor gene. Here, we identified Fra-1 as a new target of miR-34a and demonstrated that miR-34a inhibits Fra-1 expression at both protein and messenger RNA levels. In addition, we found that p53 indirectly regulates Fra-1 expression via a miR-34a-dependant manner in colon cancer cells. Overexpression of miR-34a strongly inhibited colon cancer cell migration and invasion, which can be partially rescued by forced expression of the Fra-1 transcript lacking the 3'-untranslated region. The expression of matrix metalloproteinase (MMP)-1 and MMP-9, two enzymes involved in cell migration and invasion, was decreased in miR-34a-transfected cells, and this can be rescued by Fra-1 overexpression. Moreover, we found that miR-34a was downregulated in 25 of 40 (62.5%) colon cancer tissues, as compared with the adjacent normal colon tissues and that the expression of miR-34a was correlated with the DNA-binding activity of p53. Unexpectedly, the DNA-binding activity of p53 was not inversely correlated with Fra-1 expression, and a significant statistical inverse correlation between miR-34a and Fra-1 expression was only observed in 14 of 40 (35%) colon cancer tissues. Taken together, our in vitro data suggest that p53 regulates Fra-1 expression, and eventually cell migration/invasion, via a miR-34a-dependent manner. However, in vivo data indicate that the p53-miR-34a pathway is not the major regulator of Fra-1 expression in human colon cancer tissues.
Similar articles
-
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.Oncogene. 2013 Sep 5;32(36):4294-303. doi: 10.1038/onc.2012.432. Epub 2012 Sep 24. Oncogene. 2013. PMID: 23001043
-
MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.Arch Med Res. 2010 Feb;41(2):67-74. doi: 10.1016/j.arcmed.2010.02.007. Arch Med Res. 2010. PMID: 20470934
-
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.Biochem Biophys Res Commun. 2008 Dec 5;377(1):114-9. doi: 10.1016/j.bbrc.2008.09.086. Epub 2008 Oct 1. Biochem Biophys Res Commun. 2008. PMID: 18834855
-
MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis.Mutat Res. 2010 Nov 10;693(1-2):94-100. doi: 10.1016/j.mrfmmm.2010.09.001. Epub 2010 Sep 29. Mutat Res. 2010. PMID: 20883704 Review.
-
p53 enters the microRNA world.Cancer Cell. 2007 Nov;12(5):414-8. doi: 10.1016/j.ccr.2007.10.028. Cancer Cell. 2007. PMID: 17996645 Review.
Cited by
-
Targeted biocompatible Zn-metal-organic framework nanocomposites for intelligent chemotherapy of breast cancer cells.Sci Rep. 2024 Aug 7;14(1):18311. doi: 10.1038/s41598-024-69457-6. Sci Rep. 2024. PMID: 39112669 Free PMC article.
-
MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.BMC Cancer. 2013 Jan 18;13:25. doi: 10.1186/1471-2407-13-25. BMC Cancer. 2013. PMID: 23327670 Free PMC article.
-
Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis.Genes (Basel). 2020 Aug 12;11(8):922. doi: 10.3390/genes11080922. Genes (Basel). 2020. PMID: 32806509 Free PMC article. Review.
-
Expression and function of FRA1 protein in tumors.Mol Biol Rep. 2020 Jan;47(1):737-752. doi: 10.1007/s11033-019-05123-9. Epub 2019 Oct 14. Mol Biol Rep. 2020. PMID: 31612408 Review.
-
The Fra-1/AP-1 Oncoprotein: From the "Undruggable" Transcription Factor to Therapeutic Targeting.Cancers (Basel). 2022 Mar 14;14(6):1480. doi: 10.3390/cancers14061480. Cancers (Basel). 2022. PMID: 35326630 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous